Navigation Links
Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain
Date:11/28/2008

INDIANAPOLIS, Nov. 28 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY) has withdrawn its supplemental New Drug Application (sNDA) from the U.S. Food and Drug Administration (FDA) for Cymbalta(R) (duloxetine HCl) for the management of chronic pain. Lilly plans to resubmit the application in the first half of 2009, adding data from a recently completed positive study in chronic osteoarthritis pain of the knee.

The decision does not affect duloxetine's FDA-approved indications for major depressive disorder, generalized anxiety disorder, management of diabetic peripheral neuropathic pain and management of fibromyalgia.

Lilly submitted the chronic pain application in the second quarter of 2008 based primarily on outcomes of three clinical trials: one positive study in chronic osteoarthritis pain of the knee(i) and two studies(ii,iii), -- one positive and one that is supportive but didn't meet its primary endpoint -- in chronic low back pain. In discussions between Lilly and the FDA, agency reviewers raised questions about efficacy and dosing that revolved primarily around statistical methodology and study design.

"This was a difficult decision, but we believe the updated data package will give the FDA a broader basis for reviewing our application," said John Hayes, M.D., a Lilly Research Laboratories vice president at Lilly.

Chronic pain affects more than 50 million Americans(iv) and pain is a major cause of work absenteeism, underemployment and unemployment.(v,vi,vii,viii)

About Duloxetine

Serotonin and norepinephrine in the brain and spinal cord are believed to both mediate core mood symptoms and help regulate the perception of pain. Based on preclinical studies, Duloxetine is a balanced and potent reuptake inhibitor of serotonin and norepinephrine that is bel
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Daiichi Sankyo and Lilly Respond to Speculation on Status of Prasugrel New Drug Application
2. Lilly and Deciphera Pharmaceuticals Announce Licensing and Collaboration Agreement
3. Lilly Announces Initiation of Second Global Phase III Trial of Investigational Alzheimers Disease Compound
4. Insulin Analogues From Novo Nordisk, Eli Lilly and Sanofi-Aventis Will Drive Growth in the Type 1 Diabetes Drug Market
5. Phase II Data on Lillys Antibody Show It Affects Amyloid Beta, a Protein Believed To Be Associated with Alzheimers Disease
6. FDA Extends Review Period for Daiichi Sankyo, Lilly Investigative Antiplatelet Drug, Prasugrel
7. Lilly and TransPharma Medical Announce Licensing and Development Agreement
8. Lilly Submits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration
9. Daiichi Sankyo/Eli Lillys Effient and Astrazenecas Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction
10. Lilly Launches Its First Phase III Trial for Treatment of Alzheimers Disease
11. Lilly and Transition Therapeutics Announce Licensing and Collaboration Agreement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... 14, 2014 /PRNewswire-iReach/ -- Acumed,s new SLIC Screw System ... accompanying instrumentation to place and insert the screw accurately ... tissue (e.g. ligament) repair or reconstruction as it holds ... (Photo: http://photos.prnewswire.com/prnh/20140114/MN45636 ) The ... (spacing) of the scaphoid and lunate while allowing some ...
(Date:1/14/2014)... 2014 NineSigma , Inc., the leading ... Innovation Leadership Summit , May 14-16, 2014 at the ... Ohio . This is the ... to breakthrough achievements through open innovation. Participants will learn ... across disciplines and even across industries. ...
(Date:1/14/2014)... BETHESDA, Md. , Jan. 14, 2014 /PRNewswire/ ... solutions for the healthcare industry, announced that the ... Food and Drug Administration, has released its first ... (PRO) measure in drug development: Qualification of ... Measurement of Symptoms of Acute Bacterial Exacerbation of ...
Breaking Medicine Technology:Acumed introduces the Scapho-Lunate Inter Carpal (SLIC) Screw System 2Acumed introduces the Scapho-Lunate Inter Carpal (SLIC) Screw System 3Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 2Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 3Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 4Evidera Announces Release of FDA Draft Guidance on Use of the "EXACT" to Measure Symptoms of COPD Exacerbations 2Evidera Announces Release of FDA Draft Guidance on Use of the "EXACT" to Measure Symptoms of COPD Exacerbations 3Evidera Announces Release of FDA Draft Guidance on Use of the "EXACT" to Measure Symptoms of COPD Exacerbations 4
... Netherlands, SHENZHEN, China and HUIZHOU, China, Dec. 15, 2010 ... a new disposable wireless diagnostic test platform for consumer ... for pregnancy, fertility, pathogens, AIDS, drugs, allergens and even ... will enable much more rapid diagnoses for diseases and ...
... Inc. (Nasdaq: BNVI ) today announced the publication ... cells to glucose limitation" in the journal Cell Cycle ... of the protein CC3/TIP30 in cancer cells and their ability ... of glucose and other nutrients. Lack of CC3/TIP30 in a ...
Cached Medicine Technology:Cell Phones Are Now Personal Diagnostic Tools That Can Monitor Fertility, Pathogens, AIDS, Drugs, and Allergens 2Bionovo Announces Publication Describing How Metabolic Adaptability Contributes to the Metastasis of Tumors 2Bionovo Announces Publication Describing How Metabolic Adaptability Contributes to the Metastasis of Tumors 3
(Date:4/15/2014)... the United States have nearly doubled since 1988, suggests ... Public Health, with obesity apparently to blame for the ... the disease has not hit all groups equally, with ... elderly. , According to new research reported in the ... Internal Medicine , diabetes increased from 6 percent to ...
(Date:4/15/2014)... decades-old medical mystery and in the process have found ... which kill about 1.5 million people a year. The researchers ... an antifungal drug that has been in use for more ... toxic to human cells as it is to the microbes ... findings appears in Nature Chemical Biology . , "Invasive ...
(Date:4/15/2014)... Diego School of Medicine have identified a mechanism that ... liver disease and why the virus is able to ... The hard-to-kill pathogen, which infects an estimated 200 million ... the mitochondria dismantling the cell,s innate ability to ... dynamics. , The study, published in today,s issue of ...
(Date:4/14/2014)... children orphaned by HIV/AIDS in South Africa may provide ... emotional behavior issues in other areas of the world, ... research that could lead to successful interventions. , ... the United Nations mentions that due to the HIV/AIDS ... Sub-Saharan African, children are at an increased risk for ...
(Date:4/14/2014)... International and American Associations for Dental Research (IADR/AADR) ... and Their Dental, Oral, and Craniofacial Manifestations." The ... B. Burke, Alison M. Boyce, Michael Collins, Brian ... Mary Scott Ramnitz, Martha J. Somerman and J. ... of the IADR/AADR Journal of Dental Research ...
Breaking Medicine News(10 mins):Health News:Pre-diabetes and diabetes nearly double over the past 2 decades 2Health News:Potent, puzzling and (now less) toxic: Team discovers how antifungal drug works 2Health News:Potent, puzzling and (now less) toxic: Team discovers how antifungal drug works 3Health News:Breaking bad mitochondria 2Health News:Researchers identify children with emotional behavior difficulties 2Health News:Researchers identify children with emotional behavior difficulties 3Health News:Rare bone diseases and their dental, oral and craniofacial manifestations 2
... Ontario (CHEO )researcher has found that children and babies are ... fact that generation subsists on cod liver oil, ... has persisted in too many children in Canada. ... stunts growth, the disease can cause painful bone deformities. Very ...
... has shown that regular vaccination of infants against H. ... Hib pneumonia and meningitis, could save innumerable children in ... is published online in The Pediatric Infectious Disease Journal, ... Hib conjugate vaccine prevented more than one-third of acute ...
... focused on cognitive skills may improve child behaviour. ... of the New York Academy of Sciences children who ... consideration of their own and others' emotions were found ... emotional problems. ,The study showed that ...
... to afflict humans very early, not sparing even tiny tots. Children ... in New South Wales in Australia. ,Anxiety disorders ... Macquarie University's Anxiety Research Unit show. ,In children aged ... compared to a rate of about 1 per cent for mood ...
... one bacterial species into another by swapping their genomes, a ... bugs, a pioneer on genetics said Thursday. ... genome, said a team of his researchers had transplanted the ... related species. ,The experiment marks the most ambitious ...
... in movie 'Hairspray', is happy the female costumes he wore helped ... having to wear a fat suit, dress, and high heels to ... iconic musical-turned-movie was the perfect combination to shed the pounds. ... of weight to carry around," Contactmusic quotes him as saying. ...
Cached Medicine News:Health News:Vitamin D Deficiency Still Persists in Babies 2Health News:Routine Hib Vaccination Could Save Innumerable Asian Children 2Health News:Routine Hib Vaccination Could Save Innumerable Asian Children 3Health News:Cognitive Skills Focused Curriculum may Lessen Kids' Behavioural Problems 2Health News:Anxiety Disorders Show in Tiny Tots 2Health News:Replacing a Genome Boosts Race to Develop Designer Bugs: Study 2Health News:Replacing a Genome Boosts Race to Develop Designer Bugs: Study 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: